CONCORDE ASSET MANAGEMENT, LLC – Anixa Biosciences, Inc. Transaction History
CONCORDE ASSET MANAGEMENT, LLC portfolio value:
$79,000
portfolio value
CONCORDE ASSET MANAGEMENT, LLC quarter portfolio value change:
+60.78%
quarter
Anixa Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.16% | -25 shares | 30K | $4.92 | 15.97K |
| Q2 2022 | share | 0.00% | 0 shares | 5K | $3.06 | 16K | |
| Q1 2022 | share | 0.00% | 0 shares | -4K | $2.74 | 16K | |
| Q4 2021 | share | Increase | +23.08% | 3K shares | -14K | $3.02 | 16K |
| Q3 2021 | share | 0.00% | 0 shares | 12K | $4.77 | 13K | |
| Q2 2021 | share | 0.00% | 0 shares | -11K | $3.88 | 13K | |
| Q1 2021 | share | Increase | 0.00% | 13K shares | 61K | $4.68 | 13K |